Yellow Fever Vaccination This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the latest news and research items in this category.

Yellow fever in the Democratic Republic of Congo
The Ministry of Health of the Democratic Republic of Congo (DRC) is launching an emergency mass vaccination campaign against yellow fever from 20 June 2013, following laboratory confirmation of six cases in the country on 6 June 2013. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - June 14, 2013 Category: Infectious Diseases Source Type: news

Yellow fever vaccine: Comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain.
Abstract The neurovirulence of two new candidate 17D-204 Stamaril™ working seed lots and that of two reference preparations were compared. The Stamaril™ working seed lots have been used for more than twenty years for the manufacturing of vaccines of acceptable safety and efficacy. The preparation designated RK 168-73 and provided by the Robert Koch Institute was used as a reference. It was confirmed that RK 168-73 strain was not a good virus control in our study because it has a very low neurovirulence regarding both the clinical and histopathological scores in comparison with Stamaril™ strain and is not repr...
Source: Biologicals : Journal of the International Association of Biological Standardization - June 10, 2013 Category: Biotechnology Authors: Moulin JC, Silvano J, Barban V, Riou P, Allain C Tags: Biologicals Source Type: research

Yellow fever in Ethiopia
The Ministry of Health of Ethiopia is launching an emergency mass-vaccination campaign against yellow fever from 10 June 2013.This is in response to laboratory confirmation of six cases in the country on 7 May 2013.The Ministry of Health of Ethiopia is launching an emergency mass-vaccination campaign against yellow fever from 10 June 2013.This is in response to laboratory confirmation of six cases in the country on 7 May 2013. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - May 31, 2013 Category: Infectious Diseases Source Type: news

Malcolm Brabant: 'I suffered psychosis after a routine injection'
In a powerful new book, veteran BBC correspondent Malcolm Brabant outlines his catastrophic descent into psychosis after a routine immunisation. Glenda Cooper reports on his battle for compensation, and his efforts to rebuild his life and career. (Source: Telegraph Health)
Source: Telegraph Health - May 25, 2013 Category: Consumer Health News Tags: vaccination malcolm brabant yellow fever Stamaril war correspondent Source Type: news

Quick end unlikely for yellow fever boosters
Despite the World Health Organisation declaring that a single yellow fever vaccine offers life-long immunity, travellers may need to keep taking their boosters for some time. (Source: Telegraph Health)
Source: Telegraph Health - May 22, 2013 Category: Consumer Health News Source Type: news

Yellow fever boosters may be here to stay
Despite the World Health Organisation declaring that a single yellow fever vaccine offers life-long immunity, travellers may need to keep taking their boosters for some time. (Source: Telegraph Health)
Source: Telegraph Health - May 22, 2013 Category: Consumer Health News Source Type: news

Pre‐travel Consultation: Evaluation of Primary Care Physician Practice in the Franche‐Comté Region
ConclusionsPCPs play an important role in travel medicine. This study showed that their high level of knowledge in travel medicine was mostly linked to their motivation to practice in this specialized discipline. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - May 22, 2013 Category: Infectious Diseases Authors: Emeline Piotte, Anne‐Pauline Bellanger, Gaël Piton, Laurence Millon, Philippe Marguet Tags: ORIGINAL ARTICLE Source Type: research

Yellow fever booster 'not needed' for tourists
Travellers can have life-long immunity from a single yellow fever vaccination, the World Health Organisation has said. (Source: Telegraph Health)
Source: Telegraph Health - May 21, 2013 Category: Consumer Health News Source Type: news

Yellow Fever Vaccination Booster Not Needed
Source: World Health Organization Related MedlinePlus Pages: Hemorrhagic Fevers, Traveler's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 20, 2013 Category: Consumer Health News Source Type: news

Yellow Fever Vaccination: No Booster Needed for ImmunityYellow Fever Vaccination: No Booster Needed for Immunity
A WHO report indicates that a booster vaccination is not necessary for lasting protection against yellow fever. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 20, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

A Real-Time Reverse Transcription Loop-Mediated Isothermal Amplification Assay For The Rapid Detection Of Yellow Fever Virus.
Abstract Yellow fever, a mosquito-borne disease, is an important viral hemorrhagic fever in Africa and South America where it is endemic. Detection of yellow fever virus (YFV) in Africa remains a challenge due to a lack of highly specific tests. The aim of this study was to develop and optimize a rapid detection reverse transcription loop-mediated isothermal amplification (RT-LAMP) for YFV. The RT-LAMP was done isothermally at 62°C using a real-time turbidimeter that allowed detection within 1 hr. Specificity of the RT-LAMP was determined using RNA from flaviviruses and other related viruses where only YFV RNA was...
Source: Journal of Virological Methods - May 18, 2013 Category: Virology Authors: Kwallah AO, Inoue S, Muigai AW, Kubo T, Sang R, Morita K, Mwau M Tags: J Virol Methods Source Type: research

World Briefing | Health: Single Yellow Fever Shot Offers Lifetime Protection, W.H.O. Says
One shot confers lifetime protection and the “booster shot” given at 10 years is no longer necessary, the World Health Organization said. (Source: NYT Health)
Source: NYT Health - May 17, 2013 Category: Consumer Health News Authors: By DONALD G. McNEIL Jr. Tags: Yellow Fever Vaccination and Immunization Source Type: news

Yellow fever vaccination booster not needed
17 May 2013 -- The yellow fever ‘booster’ vaccination given ten years after the initial vaccination is not necessary, according to WHO. (Source: WHO news)
Source: WHO news - May 16, 2013 Category: Global & Universal Source Type: news

Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj & Umra) for 1434 (2013)
(a) In accordance with the International Health Regulations 2005 , all travellers arriving from countries or areas at risk of yellow fever (listed below) must present a valid yellow fever vaccination certificate showing that the person was vaccinated at least 10 days prior to arrival and not more than 10 years before arrival at the border of the Kingdom of Saudi Arabia. (Source: Journal of Infection and Public Health)
Source: Journal of Infection and Public Health - May 16, 2013 Category: Global & Universal Authors: Ziad A. Memish, Abdullah A. Al Rabeeah Tags: Editorial Source Type: research

Latest outbreak news from ProMED-mail. Yellow fever outbreak—Darfur Sudan and Chad
Summary: The recent yellow fever outbreak in Darfur has been the worst in Africa in 20 years. It began on 2 September 2012. However, it was not until 30 October that samples were sent to a reference laboratory in Senegal for confirmation of the disease. On 9 November 2012, the World Health Organization (WHO) Sudan reported 266 suspected cases and 85 fatalities in 20 localities for a case fatality rate of 32%, with Central Darfur state the area hardest hit. The yellow fever vaccination plan to cover 3.5 million persons was finalized. On 13 November 2012 the WHO reported laboratory confirmation of yellow fever in two samples...
Source: International Journal of Infectious Diseases - May 2, 2013 Category: Infectious Diseases Authors: Thomas M. Yuill, John P. Woodall, Susan Baekeland Tags: Highlights from ProMED Source Type: research

Travel Characteristics and Yellow Fever Vaccine Usage Among US Global TravEpiNet Travelers Visiting Countries with Risk of Yellow Fever Virus Transmission, 2009-2011.
We describe the travel characteristics and YF vaccine use among US travelers visiting Global TravEpiNet clinics from January of 2009 to March of 2011. Of 16,660 travelers, 5,588 (34%) had itineraries to areas with risk of YF virus transmission. Of those travelers visiting one country with YF risk (N = 4,517), 71% were vaccinated at the visit, and 20% were presumed to be immune from prior vaccination. However, travelers visiting friends and relatives (odds ratio [OR] = 2.57, 95% confidence interval [95% CI] = 1.27-5.22) or going to Nigeria (OR = 3.01, 95% CI = 1.37-6.62) were significantly more likely to decline vaccination...
Source: The American Journal of Tropical Medicine and Hygiene - May 1, 2013 Category: Tropical Medicine Authors: Jentes ES, Han P, Gershman MD, Rao SR, Larocque RC, Staples JE, Ryan ET, the Global TravEpiNet Consortium Tags: Am J Trop Med Hyg Source Type: research

3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
Abstract The dengue fever virus (DENV) and the yellow fever virus (YFV) are members of the genus flavivirus in the family Flaviviridae. An estimated 50-100 million cases of DENV infections occur each year and approximately half a million patients require hospitalization. There is no vaccine or effective antiviral treatment available. There is an urgent need for potent and safe inhibitors of DENV replication; ideally such compounds should have broad-spectrum activity against flaviviruses. We here report on the in vitro activity of 3',5'di-O-trityluridine on flavivirus replication. The compound results in a dose-depe...
Source: Antiviral Research - May 1, 2013 Category: Virology Authors: De Burghgraeve T, Selisko B, Kaptein S, Chatelain G, Leyssen P, Debing Y, Jacobs M, Van Aerschot A, Canard B, Neyts J Tags: Antiviral Res Source Type: research

Coagulation factors, fibrinogen and plasminogen activator inhibitor-1, are differentially regulated by yellow fever virus infection of hepatocytes.
In this study we wanted to determine if FBG and PAI-1 expression levels by human hepatocytes was disrupted or altered by infection with either wild-type Asibi or vaccine strain17-D YFVs. Our findings indicate that YFV infection does affect the transcriptional and translational expression of FBG and PAI-1 in human hepatocytes and that these results are further affected by IL-6 during early stages of infection. These results may lead to further understanding of the molecular mechanism associated with bleeding abnormalities observed during late stage YFV infection. PMID: 23639427 [PubMed - as supplied by publisher] (Source: Virus Research)
Source: Virus Research - April 29, 2013 Category: Virology Authors: Woodson SE, Freiberg AN, Holbrook MR Tags: Virus Res Source Type: research

Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes.
Abstract Serial passaging of yellow fever virus 17D in Vero cells was employed to derive seed material for a novel inactivated vaccine, XRX-001. Two independent passaging series identified a novel lysine to arginine mutation at amino acid 160 of the envelope protein, a surface-exposed residue in structural domain I. A third passage series resulted in an isoleucine to methionine mutation at residue 113 of the NS4B protein, a central membrane spanning region of the protein which has previously been associated with Vero cell adaptation of other mosquito-borne flaviviruses. These studies confirm that flavivirus adaptat...
Source: Virus Research - April 16, 2013 Category: Virology Authors: Beasley DW, Morin M, Lamb AR, Hayman E, Watts DM, Lee CK, Trent DW, Monath TP Tags: Virus Res Source Type: research

Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: An observational cohort study
Conclusion:After YF17D immunization, moderate/severe local reactions may be more frequent in patients on systemic corticosteroid therapy. Immunogenicity seems satisfactory. Large‐scale studies are needed to confirm these results. © 2013 by the American College of Rheumatology (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - April 1, 2013 Category: Rheumatology Authors: Solen Kernéis, Odile Launay, Thierry Ancelle, Laura Iordache, Véronique Naneix‐Laroche, Frédéric Méchaï, Thierry Fehr, Jean‐Philippe Leroy, Bertrand Issartel, Jean Dunand, Diane Van der Vliet, Benjamin Wyplosz, Paul‐Henri Consigny, Thomas Hans Tags: Original Article Source Type: research

Family Compliance With Counseling for Children Traveling to the Tropics
ConclusionsA ≥80% compliance with pre‐travel counseling in children traveling overseas was achieved only for drinking bottled water, using repellents, a routine vaccine update, and yellow fever immunization. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - March 8, 2013 Category: Infectious Diseases Authors: Stéphanie Caillet‐Gossot, Rémi Laporte, Guilhem Noël, Philippe Gautret, Georges Soula, Jean Delmont, Benoit Faucher, Philippe Parola, Lindsay Osei, Philippe Minodier Tags: ORIGINAL ARTICLE Source Type: research

How Brazil joined the quest for a yellow fever vaccine.
Authors: Abstract Brazil recently announced an agreement between its Bio-Manguinhos vaccine unit and two US companies to research and develop a new yellow fever vaccine. Claudia Jurberg and Julia D'Aloisio talk to Jaime Benchimol about the controversial history of the development of the vaccine that benefits millions of people today. PMID: 23476088 [PubMed - in process] (Source: Bulletin of the World Health Organization)
Source: Bulletin of the World Health Organization - March 1, 2013 Category: Global & Universal Tags: Bull World Health Organ Source Type: research

Sudan: Third Phase of Yellow Fever Vaccination Campaign to Begin in West Darfur
[Radio Dabanga]El-Geneina -The health minister of West Darfur announced that the third phase of the vaccination campaign against yellow fever that reportedly killed 171 people across Darfur would be launched next Tuesday in the state. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 28, 2013 Category: African Health Source Type: news

Sudan: Yellow Fever Vaccination Campaign in Sudanese Refugee Camp
[Radio Dabanga]Djabal Camp -Following the emergence of yellow fever cases in the town of Goz Beida in Chad, a vaccination campaign against the disease was launched in the close by Djabal camp for Sudanese refugees in the east of the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 24, 2013 Category: African Health Source Type: news

[Comment] Dengue vaccine efficacy trial: does interference cause failure?
Live-attenuated vaccines replicate at low concentrations and elicit protective immunity without causing disease. This strategy has proven to be successful when the vaccine targets one pathogen, as is the case for vaccines against yellow fever and Japanese encephalitis viruses. Translation of this straightforward idea to target dengue has proven frustrating, because dengue is a complex flaviviral disease that is caused by not one, but four antigenically distinct dengue viruses (DENV-1, 2, 3, and 4). (Source: The Lancet Infectious Diseases)
Source: The Lancet Infectious Diseases - February 19, 2013 Category: Infectious Diseases Authors: Sathyamangalam Swaminathan, Navin Khanna, Belinda Herring, Suresh Mahalingam Tags: Comment Source Type: research

Yellow fever in Chad
The Ministry of Health of Chad is launching an emergency mass-vaccination campaign against yellow fever from 22 February 2013, following laboratory confirmation of two cases in the country in December 2012. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - February 14, 2013 Category: Infectious Diseases Source Type: news

Development of one-step quantitative reverse transcription PCR for the rapid detection of flaviviruses
Conclusion: The assay is rapid, broad-range flavivirus-specific and highly sensitive making it a valuable tool for rapid detection of flaviviruses in livestock samples, epidemiological studies or as useful complement to single flavivirus-specific assays for clinical diagnosis. (Source: Virology Journal)
Source: Virology Journal - February 14, 2013 Category: Virology Authors: Pranav PatelOlfert LandtMarco KaiserOumar FayeTanja KoppeUlrich LassAmadou SallMatthias Niedrig Source Type: research

Sudan: Yellow Fever Vaccination Campaign Started in Kabkabiya, North Darfur
[Radio Dabanga]Kabkabiya -The federal and state Ministries of Health have started a vaccination campaign against yellow fever in Kabkabiya locality, North Darfur, in collaboration with the World Health Organization. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 11, 2013 Category: African Health Source Type: news

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.
CONCLUSIONS: Despite limitations, active case-finding in the eight different countries did not find an incidence of YF vaccine associated AEFIs that was higher than previous reports. These data reinforce the safety profile of YF vaccine and support the continued use of attenuated YF vaccine during preventive mass vaccination campaigns in YF endemic areas. PMID: 23395587 [PubMed - as supplied by publisher] (Source: Vaccine)
Source: Vaccine - February 7, 2013 Category: Allergy & Immunology Authors: Breugelmans G, Lewis RF, Agbenu E, Veit O, Jackson D, Domingo-Carrasco C, Böthe M, Perea W, Niedrig M, Gessner BD, Yactayo S, on behalf of the YF AEFI group Tags: Vaccine Source Type: research

Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008-2009.
We describe the epizootics in NHPs, notified in state of São Paulo, Brazil, between September 2008 to August 2009. Ninety-one epizootic events, involving 147 animals, were reported in 36 counties. Samples were obtained from 65 animals (44.2%). Most of the epizootics (46.6%) were reported between March and April, the same period during which human cases of YF occurred in the state. Biological samples were collected from animals found dead and were sent to Instituto Adolfo Lutz, in São Paulo. Two samples, collected in two counties without an indication for YF vaccination, were positive for the virus. Another 48 animals wer...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - January 29, 2013 Category: Tropical Medicine Authors: Moreno ES, Spinola R, Tengan CH, Brasil RA, Siciliano MM, Coimbra TL, Silveira VR, Rocco IM, Bisordi I, Souza RP, Petrella S, Pereira LE, Maeda AY, Silva FG, Suzuki A Tags: Rev Inst Med Trop Sao Paulo Source Type: research

Sudan: WHO - Third Phase of Yellow Fever Vaccination Campaign to Start in Darfur
[Radio Dabanga]Khartoum -The World Health Organisation (WHO) announced that the third phase of the yellow fever vaccination campaign is scheduled to start on 26 January in Darfur. Two million people should be targeted amid the arrival of the required additional vaccines in Khartoum. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 23, 2013 Category: African Health Source Type: news

Yellow fever vaccine viremia following ablative BM suppression in AML
Novis & E G Kallas (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 21, 2013 Category: Hematology Authors: V I Avelino-SilvaF E LealE C SabinoA S NishiyaM da Silva FreireF BlummV RochaC A RodriguesY S NovisE G Kallas Source Type: research

Nigeria: Genuine Yellow Fever Cards Available in Abuja for N350
[Daily Trust]Nigerians travelling abroad need not risk their trips with fake yellow fever vaccination cards at airports as genuine vaccination cards, also known as International Certificate of Vaccination, used to certify vaccinations against yellow fever, cholera and small pox which some countries require before permitting entry to their shores, can easily be obtained at the Public Health Department at Area 3 in Abuja. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 18, 2013 Category: African Health Source Type: news

Mortality and Morbidity Among Military Personnel and Civilians During the 1930s and World War II From Transmission of Hepatitis During Yellow Fever Vaccination: Systematic Review.
Abstract During World War II, nearly all US and Allied troops received yellow fever vaccine. Until May 1942, it was both grown and suspended in human serum. In April 1942, major epidemics of hepatitis occurred in US and Allied troops who had received yellow fever vaccine. A rapid and thorough investigation by the US surgeon general followed, and a directive was issued discontinuing the use of human serum in vaccine production. The large number of cases of hepatitis caused by the administration of this vaccine could have been avoided. Had authorities undertaken a thorough review of the literature, they would have d...
Source: American Journal of Public Health - January 17, 2013 Category: Global & Universal Authors: Thomas RE, Lorenzetti DL, Spragins W Tags: Am J Public Health Source Type: research

Sudan: Central Darfur Residents Allege Vaccination Campaign Gaps
[Radio Dabanga]Mukjar -Residents of the Tockura area in Dumbar administrative unit of the Mukjar locality, Central Darfur, allege that the ongoing yellow fever vaccination campaign in the state has not covered their region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 6, 2013 Category: African Health Source Type: news

Human endogenous retroviruses and cancer prevention: evidence and prospects
DiscussionHuman endogenous retroviruses (HERVs) are a significant component of a wider family of retroelements that constitutes part of the human genome. They were originated by the integration of exogenous retroviruses into the human genome millions of years ago. HERVs are estimated to comprise about 8% of human DNA and are ubiquitous in somatic and germinal tissues.Physiologic and pathologic processes are influenced by some biologically active HERV families. HERV antigens are only expressed at low levels by the host, but in circumstances of inappropriate control their genes may initiate or maintain pathological processes...
Source: BMC Cancer - January 3, 2013 Category: Cancer & Oncology Authors: Luca CegolonCristiano SalataElisabete WeiderpassPaolo VineisGiorgio PalùGiuseppe Mastrangelo Source Type: research

Sudan: MSF helps to vaccinate 750,000 against yellow fever
PRESS RELEASE: MSF assisted the Sudan Ministry of Health to carry out the first phase of a yellow fever vaccination campaign, targeting 2.2 million people in the region of Darfur. (Source: MSF News)
Source: MSF News - December 24, 2012 Category: Global & Universal Source Type: news

Sudan: MSF helps to vaccinate 750,000 against yellow fever
PRESS RELEASE: MSF assisted the Sudan Ministry of Health carry out the first phase of a yellow fever vaccination campaign, targeting 2.2 million people in the region of Darfur. (Source: MSF News)
Source: MSF News - December 24, 2012 Category: Global & Universal Source Type: news

Antivirals: past, present and future.
ANTIVIRALS: PAST, PRESENT AND FUTURE. Biochem Pharmacol. 2012 Dec 24; Authors: De Clercq E Abstract Vaccination is possible to prevent infections with some viruses: hepatitis B virus (HBV), varicella-zoster virus (VZV), influenza A and B virus, Yellow fever virus and poliovirus; but not for others; human immunodeficiency virus (HIV), hepatitis C virus (HCV), herpes simplex virus (HSV), cytomegalovirus (CMV) and most hemorrhagic fever viruses (HFV) (except for Yellow fever virus). Antiviral therapy is obviously needed to control those infections that are not amenable to prophylaxis by vaccination, but is als...
Source: Biochemical Pharmacology - December 24, 2012 Category: Drugs & Pharmacology Authors: De Clercq E Tags: Biochem Pharmacol Source Type: research

DTaP poliovirus vaccine/hepatitis a typhoid vaccine/yellow fever vaccine: Lymphoedema in an elderly patient with breast cancer: case report
(Source: Reactions)
Source: Reactions - December 17, 2012 Category: Drugs & Pharmacology Tags: Short communication Source Type: research

Yellow fever in the Democratic Republic of Congo – update
The Ministry of Health of the Republic of Congo is launching an emergency mass-vaccination campaign against yellow fever in Ewo District in Cuvette-Ouest region, beginning next week. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - December 12, 2012 Category: Infectious Diseases Source Type: news

Yellow fever in the Republic of Congo
The Ministry of Health of the Republic of Congo is launching an emergency mass-vaccination campaign against yellow fever in Ewo District in Cuvette-Ouest region, beginning next week. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - December 12, 2012 Category: Infectious Diseases Source Type: news

Sudan: Foro Baranga Yellow Fever Campaign Starts
[Radio Dabanga]Foro Baranga -The Minister of Health of West Darfur announced the launch of the vaccination campaign against yellow fever in the locality of Foro Baranga, on Sunday 9 December. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 10, 2012 Category: African Health Source Type: news

Experimental therapies for yellow fever.
Abstract A number of viruses in the family Flaviviridae are the focus of efforts to develop effective antiviral therapies. Success has been achieved with inhibitors for the treatment of hepatitis C, and there is interest in clinical trials of drugs against dengue fever. Antiviral therapies have also been evaluated in patients with Japanese encephalitis and West Nile encephalitis. However, no treatment has been developed against the prototype flavivirus, yellow fever virus (YFV). Despite the availability of the live, attenuated 17D vaccine, thousands of cases of YF continue to occur each year in Africa and South Ame...
Source: Antiviral Research - December 10, 2012 Category: Virology Authors: Julander JG Tags: Antiviral Res Source Type: research

GAVI Needs to Offer Lower Vaccine Prices to Humanitarian Groups
DRC 2008 © Anna Surinyach An MSF staff member vaccinates a child for measles. DAR ES SALAAM/GENEVA, DECEMBER 5, 2012—The GAVI Alliance should systematically extend the discounted vaccine prices it obtains from pharmaceutical companies to humanitarian organizations that are often well placed to reach unvaccinated children, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today at the GAVI Partners Forum meeting in Tanzania. Currently, humanitarian groups such as MSF are not able to obtain vaccines at GAVI prices, and are left to n...
Source: MSF News - December 5, 2012 Category: Global & Universal Source Type: news

A Randomized, Double-Blind, Controlled Trial of the 17D Yellow Fever Virus Vaccine Given in Combination with Immune Globulin or Placebo: Comparative Viremia and Immunogenicity.
Abstract We evaluated whether coadministration of the yellow fever (YF) virus vaccine with human immunoglobulin (Ig) that contained YF virus-neutralizing antibodies would reduce post-vaccination viremia without compromising immunogenicity and thus, potentially mitigate YF vaccine-associated adverse events. We randomized 80 participants to receive either YF vaccine and Ig or YF vaccine and saline placebo. Participants were followed for 91 days for safety and assessments of viremia and immunogenicity. There were no differences found between the two groups in the proportion of vaccinated participants who developed vir...
Source: The American Journal of Tropical Medicine and Hygiene - December 3, 2012 Category: Tropical Medicine Authors: Edupuganti S, Eidex RB, Keyserling H, Akondy RS, Lanciotti R, Orenstein W, Del Rio C, Pan Y, Querec T, Lipman H, Barrett A, Ahmed R, Teuwen D, Cetron M, Mulligan MJ, for the YF-Ig Study Team Tags: Am J Trop Med Hyg Source Type: research

Sudan: Vaccination Campaigns Begin in Darfur
[Radio Dabanga]Darfur -Vaccination campaigns against yellow fever are beginning throughout Darfur this weekend. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 24, 2012 Category: African Health Source Type: news

Yellow fever in Sudan - update
The Federal Ministry of Health (FMOH) in Sudan began a 10-day mass vaccination campaign against yellow fever in Darfur on 20 November 2012, in response to the outbreak. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - November 22, 2012 Category: Infectious Diseases Source Type: news